Skip to content

Direct Pulp Capping Versus Pulpotomy for Primary Molars

Direct Pulp Capping Versus Pulpotomy Using Neo MTA for Carious Primary Molars: a Split Mouth Randomized Clinical Trial

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06973057
Acronym
MTA
Enrollment
60
Registered
2025-05-15
Start date
2023-10-01
Completion date
2026-12-31
Last updated
2025-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vital Pulp Therapies

Keywords

Vital Pulp therapies, Direct pulp capping, Pulpotomy, Neo MTA, Primary molars, Randomized clinical trial

Brief summary

Dental caries is one of the most prevalent chronic diseases worldwide. Interventions for treating deep carious lesions in teeth with no history of pain or teeth with reversible pulpitis are referred to as vital pulp therapy; these include indirect pulp treatment (IPC), direct pulp capping (DPC), and pulpotomy. Pulpotomy is considered invasive when treating exposed primary vital pulps due to caries. Less invasive vital pulp treatment methods such as DPC might, therefore, be preferable, as they reduce chair time, less tooth structure removal and a crown might not always be a necessary permanent restoration. The aim of this clinical study is to evaluate the clinical and radiographic outcomes of DPC when compared to pulpotomy in primary molars with carious pulp exposure.

Detailed description

Aim: The aim of this study is to evaluate the clinical and radiographic outcomes of direct pulp capping (DPC) when compared to pulpotomy in primary molars with carious pulp exposure using a calcium silicate-based material: neo mineral trioxide aggregate (Neo MTA). Methods: The study will be a split mouth randomized clinical trial including children between 4-9 years old. Patients will be allocated into two treatment groups; one group will start with DPC first followed by pulpotomy on the second visit, and vice versa for the second group. The time interval between both visits will be 1-2 weeks. The pulp medicament capping material (neo MTA) will be applied over the exposure site, and then tooth will be restored with glass ionomer cement and then a crown will be placed. Cases will be followed up to 24 months after initial treatment.

Interventions

PROCEDUREPulpotomy

The entire coronal pulp will be amputated to the level of canal orifices, after hemostasis, NeoMTA will be placed, then tooth will be restored with glass ionomer cement, and the tooth will be subsequently restored with a crown.

At the exposure site hemostasis will be achieved, neo MTA will be placed, then tooth will be restored with glass ionomer cement, and the tooth will be subsequently restored with a crown.

Sponsors

Jordan University of Science and Technology
CollaboratorOTHER
King Abdullah University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

A split mouth randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
4 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy patients. * Age 4-10 years. * Primary molar with deep caries present bilaterally. * Teeth should be restorable. * Clinically normal asymptomatic tooth or symptoms of reversible pulpitis (No history of pain or provoked pain subsides upon removal of the stimulus). * Radiographically: caries in the inner half of the dentin approaching the pulp.

Exclusion criteria

* History of spontaneous pain. * Soft and hard tissue pathology. * Mobility or exfoliating tooth. * No pulp exposure after caries excavation. * Inability to achieve hemostasis after 6 minutes. * Radiographically: Root resorption exceeding 1/3 of the root, apical pathology.

Design outcomes

Primary

MeasureTime frameDescription
Clinical success24 monthsNo post-treatment signs or symptoms such as sensitivity, pain, mobility or swelling should be evident.
Radiographic success24 monthsNo radiographic evidence of pathologic external or internal root resorption, periapical or furcation radiolucency.

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026